OnkoGenetiks™

Hereditary Cancer Screening Panel


OnkoGenetiks Hereditary Cancer Screening panel is designed for the targeted sequencing of genes and mutations that are associated with multiple cancer diseases. OnkoGenetiks utilizes the next-generation sequencing technology to provide more efficient and accurate targeting of specific genes or mutations, while it is able to detect very low frequency variations in cancer-associated genes.


Determine your predisposition for cancer with OnkoGenetiks™ Hereditary Cancer Screening test !



OnkoGenetiks Hereditary Cancer Screening panel is designed for the analysis of 275 genes and relevant mutations that are associated with multiple cancer diseases.

OnkoGenetiks utilizes next-generation sequencing technology to provide more efficient and accurate targeting of specific genes or mutations, while it is able to detect low frequency variations in cancer-associated genes.




Overview of OnkoGenetiks Hereditary Cancer Panel

OnkoGenetiks Hereditary Cancer Panel examines 275 genes associated with several cancer diseases. The test panel provides a comprehensive review of candidate genes to give you information that you can use now and potentially in the future, while it maximizes the chances of identifying a pathogenic cancer susceptibility variant.
OnkoGenetiks Hereditary Cancer Panel utilizes next-generation sequencing technology to broadly analyze the cancer genome and identifies all clinically relevant alterations, potentially expanding patient’s treatment options in the case of any malignancy detection.






Who should perform OnkoGenetiks Hereditary Cancer Test?

  • Individuals having a positive personal history of early-onset cancer or multiple primary cancers
  • Unaffected individuals with a positive family history of multiple generations of cancers
  • Individuals in whom the genetic diagnoses for a suspected familial cancer risk are not covered by a single targeted panel.



Why OnkoGenetiks Hereditary Cancer Panel?

  • It is very comprehensive since it analyzes 275 genes associated with hereditary cancers using next-generation sequencing technology (NGS). Thus, the answer is provided for a suspected hereditary cancer risk with a single target panel.
  • It is an economical solution with a fast result period of 21 workdays. All steps of the test are performed and reported in Genetiks Genetic Diseases Diagnosis Center.
  • The test is tailormade and clinicians can offer more personalized treatments to many cancer patients based on their genetic characteristics.
  • It is quite extensive in order to detect unaffected individuals with a family history of cancer for more than one generation.
  • It helps to determine possible treatment (therapeutic) options and drug targets for patients with a history of primary cancer.
  • A personalized genetic report is prepared after the examination of patient's clinical reports and family history by genetics experts.
  • Comprehensive genetic counseling is provided to the patient after reporting.


parallax background

General Workflow for
OnkoGenetiks Hereditary Cancer Panel :

OnkoGenetiks Hereditary Cancer Panel uses the latest genome analysis technologies (Illumina NextSeq 550 Dx) to ensure the sequencing of 275 genes with high precision. Our professional team of experts perform quality management by monitoring and controlling each stage of the analysis in order to obtain the most accurate and reliable results. The most up-to-date genome databases are used for clinical and bioinformatics analyses of the results.

The general workflow for hereditary cancer panel is outlined as the following :

OnkoGenetiks Comprehensive Cancer Screening test panel covers a total of 275 genes associated with several cancers including breast, ovary, uterus, prostate, gastric and colorectal.

How to perform OnkoGenetiks™ Hereditary Cancer Screening Test?